The rating affirmation is based on a number of factors, including Shands’ growing patient volumes, improved financial performance and relationship with Gainesville-based University of Florida College of Medicine.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Shands will perform in fiscal year 2017 as it did in FY 2016.
More articles on healthcare finance:
Fitch affirms Memorial Sloan Kettering Cancer Center’s ‘AA’ rating
9 recent hospital outlook and credit rating actions
ACA replacement could take years to draft, senator says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
